CCCC vs. MBX
CCCC (C4 Therapeutics, Inc.) and MBX (MBX Biosciences, Inc) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past year, CCCC returned 132.14% vs 242.43% for MBX. At a 0.32 correlation, their price movements are largely independent.
Performance
CCCC vs. MBX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CCCC achieves a 104.19% return, which is significantly higher than MBX's 12.59% return.
CCCC
- 1D
- 0.78%
- 1M
- 9.55%
- YTD
- 104.19%
- 6M
- 57.89%
- 1Y
- 132.14%
- 3Y*
- 1.14%
- 5Y*
- -37.89%
- 10Y*
- —
MBX
- 1D
- -4.67%
- 1M
- 9.43%
- YTD
- 12.59%
- 6M
- 18.92%
- 1Y
- 242.43%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CCCC vs. MBX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
CCCC C4 Therapeutics, Inc. | 104.19% | -46.94% | -43.84% |
MBX MBX Biosciences, Inc | 12.59% | 71.13% | -19.87% |
Correlation
The correlation between CCCC and MBX is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.31 |
Correlation (All Time) Calculated using the full available price history since Sep 13, 2024 | 0.32 |
Fundamentals
CCCC:
$491.69M
MBX:
$1.65B
CCCC:
-$1.18
MBX:
-$2.30
CCCC:
2.10
MBX:
3.78
CCCC:
$28.71M
MBX:
$0.00
CCCC:
$26.90M
MBX:
-$160.00K
CCCC:
-$107.31M
MBX:
-$96.31M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CCCC vs. MBX — Risk / Return Rank
CCCC
MBX
CCCC vs. MBX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for C4 Therapeutics, Inc. (CCCC) and MBX Biosciences, Inc (MBX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CCCC | MBX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.32 | ||
| Sortino ratioReturn per unit of downside risk | -0.90 | ||
| Omega ratioGain probability vs. loss probability | 1.28 | 1.39 | -0.11 |
| Calmar ratioReturn relative to maximum drawdown | 2.72 | 6.19 | -3.48 |
| Martin ratioReturn relative to average drawdown | 5.26 | 11.83 | -6.57 |
Loading charts...
Drawdowns
CCCC vs. MBX - Drawdown Comparison
The maximum CCCC drawdown since its inception was -97.82%, which is greater than MBX's maximum drawdown of -77.71%. Use the drawdown chart below to compare losses from any high point for CCCC and MBX.
Loading charts...
Drawdown Indicators
| CCCC | MBX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.82% | -77.71% | -20.11% |
Max Drawdown (1Y)Largest decline over 1 year | -52.10% | -37.60% | -14.50% |
Max Drawdown (3Y)Largest decline over 3 years | -90.00% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -97.82% | — | — |
Current DrawdownCurrent decline from peak | -92.28% | -17.69% | -74.59% |
Average DrawdownAverage peak-to-trough decline | -71.94% | -34.85% | -37.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 26.88% | 19.65% | +7.23% |
Volatility
CCCC vs. MBX - Volatility Comparison
C4 Therapeutics, Inc. (CCCC) has a higher volatility of 29.92% compared to MBX Biosciences, Inc (MBX) at 24.53%. This indicates that CCCC's price experiences larger fluctuations and is considered to be riskier than MBX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CCCC | MBX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 29.92% | 24.53% | +5.39% |
Volatility (6M)Calculated over the trailing 6-month period | 64.17% | 60.13% | +4.04% |
Volatility (1Y)Calculated over the trailing 1-year period | 101.41% | 135.18% | -33.77% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 117.53% | 119.14% | -1.61% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 113.01% | 119.14% | -6.13% |
Dividends
CCCC vs. MBX - Dividend Comparison
Neither CCCC nor MBX has paid dividends to shareholders.
Financials
CCCC vs. MBX - Financials Comparison
This section allows you to compare key financial metrics between C4 Therapeutics, Inc. and MBX Biosciences, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CCCC and MBX have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CCCC has higher volatility (29.92%) compared to MBX (24.53%). In terms of maximum drawdown, CCCC dropped -97.82% vs MBX's -77.71%.
MBX currently has the higher Sharpe Ratio (1.72 vs 1.40), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CCCC and MBX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer